Welcome to our dedicated page for Avantor news (Ticker: AVTR), a resource for investors and traders seeking the latest updates and insights on Avantor stock.
Avantor, Inc. (NYSE: AVTR) is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. This news page aggregates company announcements, earnings updates and other disclosures so readers can follow how Avantor’s operations, portfolio and governance evolve over time.
Recent news releases describe Avantor’s participation in investor conferences, quarterly earnings reports, leadership and board appointments, and product and service developments. Examples include announcements about the timing of quarterly and full-year earnings releases and related conference calls, as well as participation in events such as the J.P. Morgan Healthcare Conference. These items provide context on how the company communicates with the investment community and presents its financial performance.
Product- and operations-focused news highlights areas such as bioprocessing, biomanufacturing and laboratory services. Avantor has reported the launch of a sterile sampling platform and PUPSIT assemblies for bioprocessing, the development of a biodegradable viral inactivation detergent recognized with an Edison Patent Award, and the expansion of its Centralized Service Center model with a facility serving the Greater Boston area. These updates illustrate how the company positions its tools and services within scientific and industrial workflows.
Corporate governance news includes the appointment of new directors and senior executives, such as additions to the Board of Directors and the creation of an Executive Vice President and Chief Operating Officer role. Together, these news items offer insight into Avantor’s strategic priorities, leadership changes and ongoing initiatives. Investors, analysts and industry participants can use this page to monitor company communications and official announcements over time.
Summary not available.
Avantor (NYSE: AVTR) announced a quarterly cash dividend of $0.78 per share for its 6.250% Series A Mandatory Convertible Preferred Stock, translating to a rate of 1.560%. This dividend is payable on August 16, 2021 to shareholders of record as of August 1, 2021. As a leading global provider of essential products and services across life sciences and technology sectors, Avantor's substantial footprint serves over 225,000 customer locations in more than 180 countries, underscoring its influence in critical research and development activities.
Avantor, Inc. (NYSE: AVTR) has announced a change in the schedule for its second quarter 2021 earnings release. The financial results will now be disclosed after market close on July 29, 2021, followed by a conference call on July 30, 2021, at 7:30 a.m. EDT. Interested participants can join the call by dialing (866) 211-4132 domestically or (647) 689-6615 internationally. A live webcast will be available on the company’s investor webpage, with a replay accessible until August 28, 2021.
Avantor, Inc. (NYSE: AVTR), a global provider of essential products and services, will release its Q2 2021 financial results after market close on July 28, 2021. The company will host a conference call at 5:00 p.m. EDT to discuss these results. Interested participants can join via phone or through a live webcast on Avantor's investor website. The earnings press release and presentation will also be available. Avantor serves over 225,000 customer locations worldwide, emphasizing its significant role in the life sciences and advanced technologies sectors.
Avantor, Inc. (NYSE: AVTR) has successfully completed the acquisition of Ritter GmbH, enhancing its capabilities in clinical diagnostics and life sciences research. This strategic move integrates Ritter's liquid dispensing technology with Avantor's lab automation solutions, aiming to deliver greater value to biopharma and healthcare customers. Ritter, known for high-quality robotic and liquid handling consumables, specializes in various diagnostic applications, further bolstering Avantor's extensive portfolio. The acquisition received all necessary regulatory approvals.
Avantor (NYSE: AVTR) announced on June 1, 2021, the acquisition of RIM Bio, a prominent Chinese producer of single-use bioprocess bags for biopharmaceutical manufacturing. This strategic purchase enhances Avantor's capacity in the AMEA region, establishing its first single-use production plant there. The acquisition aims to leverage RIM Bio's proprietary technologies, thereby expanding Avantor's offerings in bioproduction and addressing increasing global demand in the biopharma sector. The move aligns with Avantor's ongoing investments in China.
Avantor, a global leader in mission-critical products for life sciences, will participate in the Goldman Sachs 42nd Annual Global Healthcare Conference on June 8, 2021. Michael Stubblefield, President and CEO, will represent the company starting at 9:40 a.m. EDT. A live webcast of the event will be available on Avantor's investor relations website, with a replay accessible until June 30, 2021.
Avantor serves over 225,000 locations across 180 countries, providing essential services across various industries, including biopharma and healthcare.
Avantor, Inc. (NYSE: AVTR) reported strong financial results for Q1 2021, with net sales of $1.79 billion, a 17.5% increase year-over-year. Net income surged 248.9% to $164 million, while adjusted EBITDA rose 38.2% to $363.1 million. The company achieved an adjusted net leverage of 3.5x. Significant growth was seen across all regions, particularly in AMEA, which experienced a 32.0% increase in net sales. The acquisition of Ritter is expected to enhance Avantor's product offerings. The company is on track to exceed $800 million in free cash flow for the year.
Avantor (NYSE: AVTR) will participate in a virtual fireside chat at the BofA Securities 2021 Virtual Health Care Conference on May 11, 2021. Michael Stubblefield, President and CEO, will represent the company, beginning at approximately 9:30 a.m. EDT. The event will be accessible via a live webcast on Avantor's investor relations website and will be available for replay until May 31, 2021. Avantor is a leading provider of critical products and services across multiple industries, serving over 225,000 customers in more than 180 countries.
Avantor Inc. (NYSE: AVTR) announced plans to enhance its global capacity for single-use technologies crucial in biologics and vaccine production. This expansion includes a 30% increase in manufacturing footprint and a doubling of cleanroom space across the U.S. and Europe, responding to rising demand for monoclonal antibodies, gene therapies, and COVID-19 vaccines. Recent expansions include its North Carolina facility and a new cleanroom in Devens, Massachusetts, expected by mid-year. A second European facility will also open in the Netherlands, ensuring efficient supply to biopharma clients.